Elizabeth B Lamont

Summary

Affiliation: Massachusetts General Hospital
Country: USA

Publications

  1. ncbi request reprint Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants
    Elizabeth B Lamont
    Massachusetts General Hospital, Boston, Massachusetts, USA
    Med Care 46:303-8. 2008
  2. ncbi request reprint Is patient travel distance associated with survival on phase II clinical trials in oncology?
    Elizabeth B Lamont
    Department of Medicine and Cancer Research Center, The University of Chicago, Chicago, IL, USA
    J Natl Cancer Inst 95:1370-5. 2003
  3. ncbi request reprint A demographic and prognostic approach to defining the end of life
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Palliat Med 8:S12-21. 2005
  4. ncbi request reprint Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants
    Elizabeth B Lamont
    Department of Medicine and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA
    J Natl Cancer Inst 97:1080-3. 2005
  5. pmc Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare
    Mary Beth Landrum
    Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 30:1072-9. 2012
  6. doi request reprint Tumor boards and the quality of cancer care
    Nancy L Keating
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    J Natl Cancer Inst 105:113-21. 2013
  7. doi request reprint Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration
    Mary Beth Landrum
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 118:3345-55. 2012
  8. ncbi request reprint Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA
    J Natl Cancer Inst 98:1335-8. 2006
  9. pmc Location of cancer surgery for older veterans with cancer
    Elena M Kouri
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
    Health Serv Res 47:783-93. 2012
  10. ncbi request reprint End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector
    Nancy L Keating
    The Division of General Internal Medicine, Brigham and Women s Hospital, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 116:3732-9. 2010

Detail Information

Publications30

  1. ncbi request reprint Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants
    Elizabeth B Lamont
    Massachusetts General Hospital, Boston, Massachusetts, USA
    Med Care 46:303-8. 2008
    ..Because the elderly are underrepresented on clinical trials, physicians have few sources of information to estimate the risks (ie, toxicities) and benefits of chemotherapy administration to the elderly...
  2. ncbi request reprint Is patient travel distance associated with survival on phase II clinical trials in oncology?
    Elizabeth B Lamont
    Department of Medicine and Cancer Research Center, The University of Chicago, Chicago, IL, USA
    J Natl Cancer Inst 95:1370-5. 2003
    ..We hypothesized that this phenomenon, often called "referral bias" or "distance bias," may also be evident in curative-intent cancer trials at specialized cancer centers...
  3. ncbi request reprint A demographic and prognostic approach to defining the end of life
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, Massachusetts 02114, USA
    J Palliat Med 8:S12-21. 2005
    ..Similarly, research that works to improve communication between patients and health care providers on the matter of prognosis is also needed...
  4. ncbi request reprint Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants
    Elizabeth B Lamont
    Department of Medicine and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA
    J Natl Cancer Inst 97:1080-3. 2005
    ..Administrative Medicare claims data appear to be a valid source of information for chemotherapy administered to elderly Medicare beneficiaries with cancer...
  5. pmc Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare
    Mary Beth Landrum
    Harvard Medical School, Boston, MA 02115, USA
    J Clin Oncol 30:1072-9. 2012
    ....
  6. doi request reprint Tumor boards and the quality of cancer care
    Nancy L Keating
    Department of Health Care Policy, Harvard Medical School, Boston, MA 02115, USA
    J Natl Cancer Inst 105:113-21. 2013
    ..We assessed whether the presence of a tumor board, either general or cancer specific, was associated with recommended cancer care, outcomes, or use in the Veterans Affairs (VA) health system...
  7. doi request reprint Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration
    Mary Beth Landrum
    Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 118:3345-55. 2012
    ..Many studies have documented low rates of effective cancer therapies, particularly in older or minority populations. However, little is known about why effective therapies are underused in these populations...
  8. ncbi request reprint Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA
    J Natl Cancer Inst 98:1335-8. 2006
    ....
  9. pmc Location of cancer surgery for older veterans with cancer
    Elena M Kouri
    Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA
    Health Serv Res 47:783-93. 2012
    ..Many veterans undergo cancer surgery outside of the Veterans Health Administration (VHA). We assessed to what extent these patients obtained care in the VHA before surgery...
  10. ncbi request reprint End-of-life care for older cancer patients in the Veterans Health Administration versus the private sector
    Nancy L Keating
    The Division of General Internal Medicine, Brigham and Women s Hospital, Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 116:3732-9. 2010
    ..We compared aggressiveness of end-of-life care of older metastatic cancer patients treated in the Veterans Health Administration (VHA) and those under fee-for-service Medicare arrangements...
  11. doi request reprint Understanding variation in primary prostate cancer treatment within the Veterans Health Administration
    Vinod E Nambudiri
    Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Urology 79:537-45. 2012
    ..To examine the variation in prostate cancer treatment in the Veterans Health Administration (VHA)--a national, integrated delivery system. We also compared the care for older men in the VHA with that in fee-for-service Medicare...
  12. pmc Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer
    Stacy W Gray
    Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA
    Cancer 118:1404-11. 2012
    ..The benefits of surgery in older patients and patients with multiple comorbidities are uncertain...
  13. doi request reprint Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study
    Nancy L Keating
    Brigham and Women s Hospital, Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA
    Ann Intern Med 154:727-36. 2011
    ..The Veterans Health Administration (VHA) is the largest integrated health care system in the United States. Studies suggest that the VHA provides better preventive care and care for some chronic illnesses than does the private sector...
  14. ncbi request reprint Utility of administrative claims data for the study of brain metastases: a validation study
    April F Eichler
    Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Yawkey 9E, Boston, MA 02114, USA
    J Neurooncol 95:427-31. 2009
    ..These results suggest that Medicare claims data may be used to evaluate clinical and epidemiological issues related to brain metastases in elderly cancer patients...
  15. pmc NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect?
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center, Boston, MA, USA
    J Gen Intern Med 22:1166-71. 2007
    ..We sought to estimate the effectiveness of NSAIDs in CRC prevention in the population of elderly Medicare beneficiaries, minimizing this selection bias...
  16. pmc Do socially deprived urban areas have lesser supplies of cancer care services?
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center, Boston, MA, USA
    J Clin Oncol 30:3250-7. 2012
    ..We sought to determine whether area social factors are associated with the area health care supply...
  17. ncbi request reprint Low risk of hip fracture among elderly breast cancer survivors
    Elizabeth B Lamont
    Department of Medicine, The University of Chicago, Chicago, IL, USA
    Ann Epidemiol 13:698-703. 2003
    ..Little prior work has evaluated whether women with breast cancer are at a decreased risk of osteoporotic fracture...
  18. ncbi request reprint Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to"
    Elizabeth B Lamont
    Section of General Internal Medicine, Department of Medicine, and the Cancer Research Center, University of Chicago, Chicago, IL, USA
    JAMA 290:98-104. 2003
    ..Using the vignette of a real patient with advanced cancer who far outlived her physician's prognostic estimate, we discuss clinical issues related to the science of prognosis in advanced cancer and the art of its disclosure...
  19. pmc Predictors of newly diagnosed cancer patients' understanding of the goals of their care at initiation of chemotherapy
    Inga T Lennes
    Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA
    Cancer 119:691-9. 2013
    ..In this study, the authors sought to determine whether attributes of patients and initial patient-physician encounters were associated with patients' understanding of their GOC...
  20. pmc Differences in clinical trial patient attributes and outcomes according to enrollment setting
    Elizabeth B Lamont
    Dept of Health Care Policy, Harvard Medical School, 180A Longwood Ave, Boston, MA 02115, USA
    J Clin Oncol 28:215-21. 2010
    ..We compared trial patients' attributes and outcomes by these enrollment settings...
  21. ncbi request reprint Favorable cardiac risk among elderly breast carcinoma survivors
    Elizabeth B Lamont
    Section of General Internal Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
    Cancer 98:2-10. 2003
    ..First, estrogens may be etiologic in the development of breast carcinoma and protective of CHD. Second, a common therapy for breast carcinoma (tamoxifen) may be associated with cardiac protection...
  22. ncbi request reprint Hospital-based health care use correlates with incidence of adverse events among elderly Medicare patients treated in adjuvant chemotherapy trials (Alliance 70802)
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center, Boston, MA, USA Department of Medicine, Harvard Medical School, Boston, MA, USA Department of Health Care Policy, Harvard Medical School, Boston, MA, USA Electronic address
    J Geriatr Oncol 5:230-7. 2014
    ..We sought to determine if patients' health care use in the claims is a marker of treatment morbidity...
  23. ncbi request reprint Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia
    Supriya K Gupta
    Section of Hematology Oncology, University of Chicago, Chicago, Illinois 60637, USA
    J Am Geriatr Soc 52:1681-7. 2004
    ..To estimate patterns of colon cancer presentation, diagnosis, and treatment according to history of dementia using National Cancer Institute (NCI) Surveillance, Epidemiology, and End-Result (SEER) Medicare data...
  24. ncbi request reprint Physician factors in the timing of cancer patient referral to hospice palliative care
    Elizabeth B Lamont
    Sections of General Medicine and Hematology Oncology, Department of Medicine and Cancer Research Center, University of Chicago, Chicago, Illinois, USA
    Cancer 94:2733-7. 2002
    ..In the current study, the authors attempted to determine whether the attributes of referring physicians were associated with the survival of terminally ill cancer patients in hospice...
  25. pmc Evaluation of trends in the cost of initial cancer treatment
    Joan L Warren
    Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Natl Cancer Inst 100:888-97. 2008
    ..Despite reports of increases in the cost of cancer treatment, little is known about how costs of cancer treatment have changed over time and what services have contributed to the increases...
  26. ncbi request reprint Cost of care for elderly cancer patients in the United States
    K Robin Yabroff
    Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Natl Cancer Inst 100:630-41. 2008
    ..We estimated net costs of care for elderly cancer patients in the United States for the 18 most prevalent cancers and for all other tumor sites combined...
  27. ncbi request reprint Construct validity of medicare chemotherapy claims: the case of 5FU
    Elizabeth B Lamont
    Section of Hematology Oncology, University of Chicago, Illinois 60637, USA
    Med Care 40:201-11. 2002
    ..The elderly are under represented in clinical trials of cancer therapy and the elderly who are enrolled may be unrepresentative...
  28. ncbi request reprint Patient time costs associated with cancer care
    K Robin Yabroff
    Health Services and Economics Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Natl Cancer Inst 99:14-23. 2007
    ..In this study, we estimated patient time costs associated with cancer care in patients aged 65 years and older in the United States...
  29. ncbi request reprint Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
    Cancer 106:923-30. 2006
    ..Multiple epidemiologic studies have reported associations between venous thromboembolic events and subsequent cancer diagnoses, but the published results have not suggested clear cancer screening approaches...
  30. ncbi request reprint Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer
    Theodore J Iwashyna
    Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    J Clin Oncol 20:3992-8. 2002
    ..In this study, we ask the following: (1) What is the hazard of death associated with adjuvant 5-FU in the general population of elderly stage III colon cancer patients? (2) Does the hazard vary with patient age?..